These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 8538196)

  • 1. Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase?
    Alberts DS; Hixson L; Ahnen D; Bogert C; Einspahr J; Paranka N; Brendel K; Gross PH; Pamukcu R; Burt RW
    J Cell Biochem Suppl; 1995; 22():18-23. PubMed ID: 8538196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels.
    Piazza GA; Alberts DS; Hixson LJ; Paranka NS; Li H; Finn T; Bogert C; Guillen JM; Brendel K; Gross PH; Sperl G; Ritchie J; Burt RW; Ellsworth L; Ahnen DJ; Pamukcu R
    Cancer Res; 1997 Jul; 57(14):2909-15. PubMed ID: 9230200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
    Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
    Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process.
    Reddy BS; Kawamori T; Lubet RA; Steele VE; Kelloff GJ; Rao CV
    Cancer Res; 1999 Jul; 59(14):3387-91. PubMed ID: 10416599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulindac and a cyclooxygenase-2 inhibitor, etodolac, increase APC mRNA in the colon of rats treated with azoxymethane.
    Kishimoto Y; Takata N; Jinnai T; Morisawa T; Shiota G; Kawasaki H; Hasegawa J
    Gut; 2000 Dec; 47(6):812-9. PubMed ID: 11076880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piroxicam and other cyclooxygenase inhibitors: potential for cancer chemoprevention.
    Earnest DL; Hixson LJ; Alberts DS
    J Cell Biochem Suppl; 1992; 16I():156-66. PubMed ID: 1305681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of NSAIDs for the chemoprevention of colorectal cancer.
    Herendeen JM; Lindley C
    Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention.
    DuBois RN; Giardiello FM; Smalley WE
    Gastroenterol Clin North Am; 1996 Dec; 25(4):773-91. PubMed ID: 8960892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer.
    Levy GN
    FASEB J; 1997 Mar; 11(4):234-47. PubMed ID: 9068612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsteroidal anti-inflammatory drugs, COX-2 and colorectal cancer.
    Patrignani P
    Toxicol Lett; 2000 Mar; 112-113():493-8. PubMed ID: 10720771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposis.
    Giardiello FM; Spannhake EW; DuBois RN; Hylind LM; Robinson CR; Hubbard WC; Hamilton SR; Yang VW
    Dig Dis Sci; 1998 Feb; 43(2):311-6. PubMed ID: 9512123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.
    Rao CV; Rivenson A; Simi B; Zang E; Kelloff G; Steele V; Reddy BS
    Cancer Res; 1995 Apr; 55(7):1464-72. PubMed ID: 7882354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
    Gill S; Sinicrope FA
    Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac.
    Agarwal B; Rao CV; Bhendwal S; Ramey WR; Shirin H; Reddy BS; Holt PR
    Gastroenterology; 1999 Oct; 117(4):838-47. PubMed ID: 10500066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is inhibition of cyclooxygenase required for the chemopreventive effect of NSAIDs in colon cancer? A model reconciling the current contradiction.
    Rigas B; Shiff SJ
    Med Hypotheses; 2000 Feb; 54(2):210-5. PubMed ID: 10790755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs.
    Pereira MA
    Adv Exp Med Biol; 1999; 470():55-63. PubMed ID: 10709674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase as a target for colorectal cancer chemoprevention.
    Moreira L; Castells A
    Curr Drug Targets; 2011 Dec; 12(13):1888-94. PubMed ID: 21158711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of gastrointestinal cancer--the potential role of NSAIDs in colorectal cancer.
    Luk GD
    Schweiz Med Wochenschr; 1996 May; 126(19):801-12. PubMed ID: 8693304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colon cancer prevention by NSAIDs: what is the mechanism of action?
    Ahnen DJ
    Eur J Surg Suppl; 1998; (582):111-4. PubMed ID: 10029375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.